Clinical Trial Update: The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series

View source ↗

Summary

A terminated clinical trial case series evaluating ACell MicroMatrix and Cytal Wound Matrix for pilonidal wounds; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pilonidal Disease

Drugs mentioned

• ACell MicroMatrix (ACell MicroMatrix)
• Cytal Wound Matrix

Snippet

Sponsor: Integra LifeSciences Corporation | Conditions: Pilonidal Disease | Status: TERMINATED | Results posted: 2020-07-15